Basit öğe kaydını göster

dc.contributor.authorHaymana, Cem
dc.contributor.authorDAĞDELEN, SELÇUK
dc.contributor.authorSalman, Serpil
dc.contributor.authorAta, Naim
dc.contributor.authorŞAHİN, İBRAHİM
dc.contributor.authorCakal, Erman
dc.contributor.authorATMACA, AYŞEGÜL
dc.contributor.authorSahin, Mustafa
dc.contributor.authorCelik, Osman
dc.contributor.authorDemir, Tevfik
dc.contributor.authorErtugrul, Derun
dc.contributor.authorÜNLÜTÜRK, UĞUR
dc.contributor.authorCaglayan, Murat
dc.contributor.authorSatman, Ilhan
dc.contributor.authorSonmez, Alper
dc.contributor.authorDemirci, Ibrahim
dc.contributor.authorTasci, Ilker
dc.contributor.authorEmral, Rifat
dc.date.accessioned2021-12-10T12:49:57Z
dc.date.available2021-12-10T12:49:57Z
dc.identifier.citationSonmez A., Demirci I., Haymana C., Tasci I., DAĞDELEN S., Salman S., Ata N., ŞAHİN İ., Emral R., Cakal E., et al., "Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)", JOURNAL OF DIABETES, 2021
dc.identifier.issn1753-0393
dc.identifier.otherav_dae27ce0-0665-42cc-92ac-54636f83eb06
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174789
dc.identifier.urihttps://doi.org/10.1111/1753-0407.13171
dc.description.abstractBackground Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe course in patients with type 2 diabetes mellitus (T2DM). However, severe adverse outcomes are not recorded in all patients. In this study, we assessed disease outcomes in patients with and without T2DM hospitalized for COVID-19.
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectEndocrinology
dc.subjectEndocrine and Autonomic Systems
dc.subjectEndocrinology, Diabetes and Metabolism
dc.subjectLife Sciences
dc.titleClinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)
dc.typeMakale
dc.relation.journalJOURNAL OF DIABETES
dc.contributor.departmentGulhane Military Medical Academy , ,
dc.contributor.firstauthorID2607069


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster